Back

PRIME Education, Inc. (PRIME®)

  • Molecular Targeted Therapy
  • Neuroendocrine Tumors

Mastering Recent Advances in Targeted Therapy for GEP-NETs

Stay at the forefront of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) management by applying recent advances in targeted therapies. This activity will help you evaluate the latest clinical data, apply current guidelines, and integrate emerging evidence to select and sequence treatments effectively. In this interactive case-based simulation, you will: Assess the most recent clinical data on current and emerging therapies Learn to tailor evidence-based, patient-centered treatment plans Implement approaches to reduce symptom burden, and enhance quality of life for patients with GEP-NETs.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.25 creditsAAPA Category 1 Credit™Up to 0.25 creditsAMA PRA Category 1 Credit™Up to 0.25 creditsNursingUp to 0.25 creditsPharmacyUp to 0.25 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Virtual patient / simulation
  • Credit · Up to 0.25 credits
  • Commercial Support
  • Released
    Nov 14, 2025
  • Last day to claim credit
    Nov 14, 2026 5 weeks left